Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Cash flows from operating activities:
Net (loss) income	$ (7,181)	$ 3,049
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	1,033	1,191
Imputed interest on contingent consideration	108	40
Share-based compensation expense	383	472
Provision for losses on accounts receivable	7,855	125
Deferred income tax (benefit) expense	(3,086)	108
Changes in assets and liabilities:
Accounts receivable	18,891	(5,184)
Prepaid expenses and other current assets	2,270	483
Net of transit accounts receivable and payable	1,056	923
Accounts payable and accrued expenses	1,508	(3,366)
Accrued payroll and related costs	825	(1,986)
Right of use assets and liabilities	(16)	245
Income taxes payable	94	30
Total adjustments	30,921	(6,919)
Net cash provided by (used in) operating activities	23,740	(3,870)
Cash flows from investing activities:
Property and equipment acquired	(400)	(301)
Decrease in deposits	40	5
Net cash used in investing activities	(360)	(296)
Cash flows from financing activities:
Borrowings under line of credit	51,366	72,201
Repayments under line of credit	(72,869)	(68,006)
Issuance of stock for employee stock purchase plan	208	321
Changes in finance lease obligations	(321)	218
Contingent consideration paid	(345)	(574)
Payment of note payable for treasury stock	(2,230)
Net cash (used in) provided by financing activities	(24,191)	4,160
Effect of exchange rate changes on cash and cash equivalents	(279)	(83)
(Decrease) increase in cash and cash equivalents	(1,090)	(89)
Cash and cash equivalents at beginning of period	1,847	482
Cash and cash equivalents at end of period	757	393
Supplemental cash flow information:
Interest	922	1,266
Income taxes	191	116
Non-cash financing activities:
Equity awards issued	364	300
Dividends forfeited on unvested restricted share units		(12)
Software purchase under finance lease	$ 258